Dr. Fadi Eskandar

- Lead CNS and Pain cross-functional multinational development project teams - Contribute to the creation of the CNS and Pain Therapeutic Area Strategy - Apply state-of-the-art portfolio management processes to maximize the value/risk profile of the portfolio - Drive the creation and endorsment of integrated development and implementation plans - Coordinate the assessment of new potential asset targets and preparation of the regular reviews of the existing projects pipeline

- Define and implement strategic development of inhalation products and technologies. - Maintain competitiveness in the inhalation area by scouting for, identifying and se-curing external technologies/ products. - Act as an expert in the inhalation product area. - Provide technical sales support to Business Development in interactions with partners and potential partners. - Represent Skyepharma’s inhalation business area at meetings, congresses and in high-class publications.

- Lead the brand digital strategy across the globe - Support integrated Brand strategy development - work closely with Medical affairs teams to develop a competitive strategy - Plan booths at international congresses and customer meetings - Develop a customer engagement plan and arrange advisory borads - Work closely with patient association to develop a disease awareness campaign - Support brand growth in Asia Pacific and Middle East

Operationally managed Primary Care Portfolio - Implement Franchise strategy - Support restructuring activities to increase efficiency - Act as point of contact for Primary care worldwide heads covering 95 countries - Plan the Franchise worldwide events, virtual meetings and Townhalls

Managing global cross functional team to develop three pharmaceutical products including medical devices and telehealth - Prepare integrated development project plan - Operationalize the clinical development plan - Prepare device development and E-Health development plans

- Lead formulation development of Dry Powder Inhalation combination product - Successful scaling up of one inhaled product from Phase II enabling successful launch - Lead formulator for several DPI projects developed for global markets: DoE planning, execution and statistical read out; manufacturing process scale up and validation; preparation of development reports; preparation of regulatory quality documents

- Develop inhaled insulin formulation from lab to pilot scale - Build an aerosol Characterization laboratory & train the staff - Support device development for novel inhalers - Scaling-up and technology transfer for full GMP manufacturing of aseptic processes - Drive outsourcing strategy - Support BD&L in scouting for news technologies and completing due diligences

- Developing inhalers for pulmonary applications - Galenic formulation optimization of peptides and proteins for treatment of lung cancer - Characterize inhaled products

Corporate Strategy, Entrepreneurship, Organisational Leadership, Design Thinking, Digital Transformation, New Marketing trends, Business Administration, Management, Leading Talents, Positive Leadership, Finance and accounting.

Master Thesis: "Innovation Through Cooperation in The Pharmaceutical Industry: A forward looking strategy"

Marketing, business adminstration, innovation managment & organization management. Master Thesis: "An optimal model for Managed care in the pharmaceutical industry: A business plan"

Ph.D. in pharmaceutics and biopharmaceutics with focus on inhaled therapy. Ph.D. Theis: "Cyclosporin A for pulmonary application: A novel formulation approach"

graduated as pharmacist